Éva Áy

Dr. Éva Áy


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2021 in Acta Microbiologica Et Immunologica Hungarica
Verified
Journal Article
Open access
PDF file
ÉÁÉva Áy
Éva Áy
ÁPÁgnes Pocskay
Ágnes Pocskay
BLBotond Lakatos
Botond Lakatos
JSJános Szlávik
János Szlávik
MMMária Mezei
Mária Mezei
JMJános Minárovits
János Minárovits
Widespread introduction of HIV integrase inhibitors into clinical care may result in appearance of drug resistance mutations affecting treatment outcome. The aim of our study was to monitor the resistance patterns of integrase inhibitors beside protease and reverse transcriptase inhibitors in newly diagnosed therapy-naive HIV-positive patients in Hungary between 2017 and 2019.Genotype-based resistance testing of HIV integrase, protease and reverse transcriptase was performed by amplification and Sanger population sequencing from plasma samples. Drug resistance mutations were identified by the algorithm of Stanford HIV Drug Resistance Database.Potentially transmitted, non-polymorphic integrase major mutation was detected in 1 out of 249 samples, while accessory mutations were observed in further 31 patients (12.4%). The overall prevalence of transmitted drug resistance (TDR) mutations related to protease and reverse transcriptase inhibitors was 5.8% (10/173) between the end of 2017 and 2019. Nucleoside reverse transcriptase inhibitor associated resistance mutations were the most frequent indicators of TDR (6/173; 3.5%), followed by resistance mutations associated with protease (3/173; 1.7%) and non-nucleoside reverse transcriptase inhibitors (2/173, 1.2%).The first detection of integrase major mutation and the changing patterns of other resistance mutations in Hungarian untreated HIV-positive population indicate the necessity of continuous molecular surveillance of Hungarian HIV epidemic.

24 November 2024 in Viruses
Verified
Journal Article
Open access
PDF file
LZLevente Zsichla
Levente Zsichla
MZMarius Zeeb
Marius Zeeb
DFDavid Fazekas
David Fazekas
ÉÁÉva Áy
Éva Áy
DMDalma Müller
Dalma Müller
VMViktor Müller
Viktor Müller
The increasingly widespread application of next-generation sequencing (NGS) in clinical diagnostics and epidemiological research has generated a demand for robust, fast, automated, and user-friendly bioinformatics workflows. To guide the choice of tools for the assembly of full-length viral genomes from NGS datasets, we assessed the performance and applicability of four open-source bioinformatics pipelines (shiver—for which we created a user-friendly Dockerized version, referred to as dshiver; SmaltAlign; viral-ngs; and V-pipe) using both simulated and real-world HIV-1 paired-end short-read datasets and default settings. All four pipelines produced consensus genome assemblies with high quality metrics (genome fraction recovery, mismatch and indel rates, variant calling F1 scores) when the reference sequence used for assembly had high similarity to the analyzed sample. The shiver and SmaltAlign pipelines (but not viral-ngs and V-Pipe) also showed robust performance with more divergent samples (non-matching subtypes). With empirical datasets, SmaltAlign and viral-ngs exhibited an order of magnitude shorter runtime compared to V-Pipe and shiver. In terms of applicability, V-Pipe provides the broadest functionalities, SmaltAlign and dshiver combine user-friendliness with robustness, while the use of viral-ngs requires less computational resources compared to other pipelines. In conclusion, if a closely matched reference sequence is available, all pipelines can reliably reconstruct viral consensus genomes; therefore, differences in user-friendliness and runtime may guide the choice of the pipeline in a particular setting. If a matched reference sequence cannot be selected, we recommend shiver or SmaltAlign for robust performance. The new Dockerized version of shiver offers ease of use in addition to the accuracy and robustness of the original pipeline.

16 December 2025 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
LZLevente Zsichla
Levente Zsichla
LALilla Adravecz
Lilla Adravecz
DMDalma Müller
Dalma Müller
PLPhilippe Lemey
Philippe Lemey
ÁLÁron Lakatos
Áron Lakatos
VMViktor Müller
Viktor Müller
Introduction: Although antiretroviral therapy can suppress the transmission of HIV-1, the pandemic persists and continues to evolve. Monitoring virus transmission patterns and evolving variants is therefore essential for improving prevention strategies. To address this need, we present the first comprehensive molecular epidemiological analysis of the HIV-1 epidemic in Hungary—a country in the contact zone of major HIV-1 subtypes A, B, and F. Methods: We analyzed partial pol sequences obtained from 1,120 Hungarian patients in the context of routine drug resistance genotyping between 2008 and 2024, along with 2,202 international background sequences selected based on sequence similarity. We performed subtyping, drug resistance testing, maximum likelihood and Bayesian phylogenetic inference, distance-based and phylogenetic clustering, and Bayesian phylogeographic analyses to identify domestic clusters and cross-border transmission. Results: Most sequences (814/1,120) belonged to subtype B; however, the frequency of non-B subtypes (mainly A, F, and several recombinant forms) has increased steadily since 2014, reaching 41.3% in 2024. Phylogenetic analyses identified 136 domestic clusters and a large transmitted drug resistance clade persisting over two decades. Remarkably, one in six recent diagnoses mapped to a single cluster, and approximately a third of all new diagnoses to the five most active clusters. Individuals in larger clusters were more often young, men who have sex with men (MSM), and had higher CD4+ counts. While the most affected risk group is still MSM, suspected heterosexual cases have increased recently, with a clear separation between sub-epidemics. Incorporation of international sequences revealed 149 mixed clusters, 56 mixed monophyletic pairs, and at least 122 independent introductions, linking the Hungarian epidemic predominantly to other European countries (Germany, UK, Poland, Spain, Italy, and Croatia for subtype B; Russia and Poland for subtype A; Romania for subtype F, Italy for CRF18_cpx), and to more distant sources for CRF01_AE (Thailand, China), CRF02_AG (Spain, Cameroon) and CRF56_cpx (Turkey). Discussion: In summary, recent HIV infections in Hungary stem mainly from domestic transmission among MSM, with a few highly active transmission clusters underscoring the need for targeted interventions. The epidemic is most strongly linked to Western and Central Europe, with increasing introductions and spread of non-B subtypes from Eastern Europe and beyond.